Subject: File No. S7-19-07
From: Tony Ryals
Affiliation: 'Dr.' David P 'Naked Shorts' Summers a banker ?

February 7, 2008

Well I guess those here,(it appears most),who enjoy the pain and suffering of others,(particularly me),being defrauded, should enjoy this.I stopped by the old veeerrry old ragingbull.con scam 'message board' only to find the long time posters and touters who no doubt are themselves insiders to the fraud - (they never complained when my shares went to 0 on fraudulent claims of Endovasc shares being naked shorted and in fact that was their claim as well so no doubt they were being re-supplied with almost unending supplies of worthless shares to dump which I was not because they never cried ouch either)- complaining that 'Dr.' David P Summers had indeed reappeared and was using the very same 'nicotinic receptor' scam he got from Stanford University as well as James Dale Davidson's claim to having somehow re-discovered and re-patented the scam himself with 'Dr.' Summers in 2002 or 2003 which he then touted on his Agora Inc 'Vantage Point' tout site.
Anyway this is such a long convoluted lie and fraud I have been permanently sickened and poisoned by it,probably permanently.So it would appear now that Summers has with little fanfare repackaged the fraud into another scammy 'biotech' pump and dump shell called METABOLIC RESEARCH, INC..So in effect both Endovasc (EVSC now) and METABOLIC RESEARCH, INC. are both touting the same snake oil at the same time.

Uh but what the heil - the fraudsters posing as medical researchers at Stanford University had already done that
long before they asked Endovasc(at my request)to stop touting the Stanford nicotine 'angiogenesis' patent they claimed to be the patentors of I believe in 2004.However,funny or not so funny enough,the Stanford fraudsters 'Dr.' Chris Heeschen and 'Dr.'John Cooke(who themselves must have done well for themselves when the Israeli Grin brothers(Abraham and David and maybe one other,hee),touted and pumped the worthless shares to around $15 per share before they collapsed just as quickly.(AND AGAIN RIGHT ON AND AT 9/11 FROM 3 CENTS TO 24 CENTS )

But by 2004 'Dr.'John Cooke had found a new group of offshore scamsters or 'angel investors' and created a South San Francisco 'company' called Athenagen I believe it was and were no doubt planning to find another Nevada shell to pump and dump and launder offshore from - Asia maybe Kuala Lumpur or something like that.In fact I believe after I bashed their fraud publically here and on the indymedias that is why they changed their company name to something else and still kept on keeping on with the scam as far AS I KNOW - MEANING AT LEAST 3
SCAM 'COMPANIES' - Endovasc,METABOLIC RESEARCH, INC.,and what ever the new name for the Stanford scamsters company is - all claim to hold some right to the 'acetylcholine receptors' of my and yours' and everyones' cells ?

But HA IT GETS WORST All this chatter on ragingbull.con's
EVSC 'message board' led me to look at the METABOLIC RESEARCH, INC SEC filing mentioning the scamster Summers who always led
EVSC investors or suckers to believe he was a medical doctor or researchers with more patents than a general had medals.
I had some time ago ran across what I thought was another David P SUMMERS WHO WAS A BANKER(Community Bank of Northern Virginia),BUT I CONCLUDED THAT COULDN'T BE ENDOVASC'S David P SUMMERS .

However a very brief perusal of METABOLIC RESEARCH, INC.
filings that listed other insider relations of David P Summers tonight proved me wrong.Listed among the scam companies Summers has used to pump and dump and defraud investors besides the 'biotechs' AMERICAN BIOMED INC and Endovasc that he and the now deceased Dwight Cantrell along with James Dale Davidson and Judge Ken Reilly allowed the famed billionaire trial attorney John O'Quinn to deceive into believing their illegal pumps and dumps were really 'naked shorting' or 'naked short selling'(a term I don't believe existed until 1999 that was when the claim was posted by an anonymous scamster on then promoted over the internet by Davidson, :






I never remember seeing Summers in an SEC filing that made that connection before(the bank - or now - banks).Well - I'm gonna be sick,I mean sicker.Yes indeed all these years Dr. or Mr. David P Summers playing at being a medical researcher and inventor of patents in Texas was leading a double life and no doubt more(I believe like James Dale Davidson he also has Beltway and probavbly CIA or NSA connections in order to run his frauds and scams so easily with the SEC's and Christopher
'Naked Shorts' Cox's blessings.In fact I believe Summers did make at least a cameo appearance in that Arkansas biotech scam the FBI appeared in as well as - was it the USXP or that golf
penny stock company what's his name posted about here a year or more ago ? Oh what a fraudulent web the weave - seemingly with the SEC's and CHRISTOPHER COX'S APPROVAL.

I do know around 9/11 that Summers released an Endovasc press release now unavailble on internet saying he was coincidentally in Washington D.C. AND NOT TEXAS AT THE TIME - SUPPOSEDLY DOING SOMETHING WITH THE FDA OR SOMETHING.ANYWAY THE POST 9/11 WORLD APPEARS TO HAVE BEEN VERY GOOD TO HIM.How nice.

- Tony Ryals

Endovasc Inc (RB: EVSC)

EVSC Message list
By: v6premium
02 Feb 2008, 08:24 AM EST
Msg. 20669 of 20674
Jump to msg. #
Is this new or old ?? HELP


Should I buy with my winnings from EVSC ?
- - - - -

By: meangene53
02 Feb 2008, 09:20 PM EST
Msg. 20670 of 20674
(This msg. is a reply to 20669 by v6premium.)
Jump to msg. #
I noticed the eggplant extract in the ingredients.That's where they are getting the nicotine.It seems like Summers is ripping us off again.I thought we had the nicotine patent.Now that Summers may be making money how about Dottavio continuing to follow up on the lawsuit that isn't resolved yet.If I remember correctly Summers is still liable for the naked shorting and his fudiciary duties(or the lack thereoff).Interesting post
By: meangene53
02 Feb 2008, 09:30 PM EST
Msg. 20671 of 20674
Jump to msg. #
We've been fu%$## by Summers again.I don't know how our CEO can stand back and do nothing about this.Summers is rewarded for being a fraud and is back in business loading up his pockets while we've all been hoodwinked.How did he get away with it and when did it happen.All of his products are from EVSD/NDA Technology.We have the patent and I'm tired of Dottavio doing nothing....eom...Do I sound like endobutt now?
EVSC Message list Reply to msg.
By: v6premium
03 Feb 2008, 10:25 AM EST
Msg. 20672 of 20674
Jump to msg. #
Not endobutt ...
you are just asking good questions. I can only hope Dr. D reads these posts and is aware, unless it is just hopeless at this time or she is in on the scheme. One thing, sales of Endothil CR still seem to be strong and the product is well liked, not that any of that matters anymore.
By: meangene53
04 Feb 2008, 03:36 AM EST
Msg. 20673 of 20674
(This msg. is a reply to 20669 by v6premium.)
Jump to msg. #
I couldn't believe how long mtbr.ob has been around.By doing some research it looks attractive.....OH No,,Endovasc againRUN FOR YOUR LIFE
By: different_drummer0
04 Feb 2008, 11:41 AM EST
Msg. 20674 of 20674
(This msg. is a reply to 20673 by meangene53.)
Jump to msg. #
Interesting reads, y'all...

Sounds like a patent infringement to me...but what do I know?

Let's just hope Dr. D is aware of the situation.

As for the Endobutt comment: Nahhh. You'll need to repeat yourself here and via numerous free bulletin boards with numerous links "interlinking" to each other...THEN you're close to being an Endobutt-wannabe.

Well, how about Nige? Nah. You'll need to say "sheeples" several times too. Didn't do that, lol.

(To the newbies: Endobutt..a nickname toward his previous handle "Endoscam"...used to visit this board with volumes of negative postings then goes out in the Web and "deposits" like Johnny Appleseed).

So who has the time to do all that??? Endobutt, of course.


Records 1 - 25 of 103.






Get a Free Trial of EDGAR Online Pro Click here


Community Bank of Northern Virginia Announces Fourth Quarter 2004 and Record 2004 Net Income
Business Wire, Jan 25, 2005
STERLING, Va. -- Community Bank of Northern Virginia (Nasdaq:CBNV) today announced fourth quarter 2004 net income of $2.419 million, or $0.23 per diluted common share, compared to $2.143 million, or $0.21 per diluted common share for the same period last year, an increase of 13%. Return on average equity for the fourth quarter 2004 was 16.02% compared to 15.60% for the same period last year. Return on average assets for the fourth quarter 2004 was 1.08% compared to 1.13% for the same quarter last year.

For the year ended December 31, 2004, record net income of $9.119 million, or $0.88 per diluted common share, was achieved compared to $7.878 million, or $0.77 per diluted common share for the same period last year, an increase of 16%. Return on average equity for 2004 was 15.76% compared to 14.63% for 2003. Return on average assets for 2004 was 1.08% compared to 1.11% for the same period last year.

Commenting on 2004 results, David P. Summers, President and Chief Executive Officer, stated, "We are pleased to report record net income for 2004. We achieved strong loan and deposit growth even as competitive pressures became more intense in our marketplace. This milestone was also achieved despite a higher than normal net charge-off ratio. With asset quality improved at year-end 2004 and plans underway to further expand our Northern Virginia footprint, 2005 is expected to be another year of strong performance."

Key highlights of 2004 vs. 2003
Item 1.01
Entry into a Material Definitive Agreement.
Assignment Agreement

In furtherance of the Assignment Agreement entered into between
Metabolic Research, Inc.(the "Registrant") and Dr. David P. Summers and T.W. Owen in Dated April 25, 2007, the Registrant obtained an exclusive, irrevocable, assignment of certain technologies relating to the use of fungi,
plants, or animals for the production of anti-inflammatory and analgesic
products for the treatment of inflammatory diseases. In consideration for the
assignment, the Registrant issued two million five hundred thousand shares of its common stock to Dr. Summers and T W

Item 3.02
Unregistered Sales of Equity Securities.

The disclosure set forth above under Item 1.01 (Entry into a Material
Definitive Agreement) is hereby incorporated by reference into this Item 3.02.

On April 25, 2007, the Registrant issued 2,500,000 shares of its common
stock to Dr. David P. Summers and T. W. Owen (1,250,000 shares to each of
Messrs. Summers and Owen). Such shares were issued pursuant to and in
accordance with the Assignment Agreement, dated April 25, 2007, between the
Registrant, Dr. Summers, and T W Owen. In consideration for the issuance of
such shares, Dr. Summers and T W Owen granted to the Registrant an assignment
to develop products based on the technologies described above under Item
1.01. The shares were issued pursuant to the exemption from registration
available under Section 4(2) of the Securities Act of 1933, as amended.


The disclosure set forth above under Item 1.01 (Entry into a Material
Definitive Agreement) is hereby incorporated by reference into this Item 5.02.

Item 5.01
Change in Control.

On April 25, 2007, majority control of the company changed with Dr.
David P. Summers and T.W. Owen now controlling over 50% of the issued and
outstanding stock. On April 27, 2007, the Company began its reorganization by
incorporating in Nevada and redomiciling the Company in Nevada and filing its
Articles of Merger.

Item 5.02
Departure of Directors or Principal Officers Election of Directors
Appointment of Principal Officers.

On or about April 30, 2007, the Company appointed Dr. Summers as CEO,
President and Director and T.W. Owen as CFO, Secretary/Treasurer and Director.

From 1996 to 2004 Dr. Summers was Chairman of the Board, and CEO of
Endovasc, Inc., Montgomery, Texas. Dr. Summers founded the company and
commenced commercializing patents conveyed to the company. Since 2004, Dr.
Summers has been CEO of Partners In Science Holdings, Inc., a nutraceutical
research and development company. Dr. Summers educational background
includes: Doctor of Philosophy (PhD, Economics), Kennedy Western University,
1992 Doctor of Science (D.Sci, Medicine), Belford University, 1994 Master of
Business Administration (MBA) Pepperdine University, l984.

T.W. Owen has over 38 years of experience as a management and marketing

Neither T W Owen nor Dr. Summers has been affiliated with any company
that has filed for bankruptcy within the last five years. Neither of them has
any family relationships with each other or with any of the directors or other
executive officers of the Registrant. There were no transactions during the
last two years, or any proposed transactions, to which the Registrant was or
is to be a party, in which either T W Owen or Dr. Summers had or is to have a
direct or indirect material interest.

8-K Last Page of 3 TOC 1st Previous Next Bottom Just 3rd

Item 9.01
Financial Statements and Exhibits.
(a) Financial statements of businesses acquired.
Not Applicable

(b) Pro forma financial information.
Not Applicable

(c) Shell company transactions.
Not Applicable

(d) Exhibits.

Exhibit No. Description
10.3 Assignment Agreement, dated April 25, 2007,
among the Registrant, Dr. David P. Summers and
T.W. Owen


Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.

Date: May 3, 2007


Dr. David P. Summers
By /s/----------------------
Dr. David P. Summers
Chief Executive Officer,
and Director


Dr. David P. Summers
Dr. David P. Summers serves as our Chief Executive Officer and Chairman. Dr. Summers has served in this capacity on a full-time basis since our inception and is primarily responsible for our operations as a whole. Prior to working with Endovasc, Dr. Summers founded American BioMed, Inc. and served as its President and Chief Executive Officer from 1984 to 1995.

Dr. Summers is a Fellow in the American College of Angiology, a Fellow in the International Society for Endovascular Surgery, as well as the inventor of several medical devices used to treat cardiovascular diseases. He is the author of 25 issued patents and has 8 patents pending. Prior to founding American BioMed, Dr. Summers assisted with the management of several corporations, including C.R. Bard, Inc., a manufacturer and distributor of cardiovascular medical products Karl Stortz Endoscopy, an endoscopic instrument company and Pall Corporation, a manufacturer and distributor of blood filtration products.

Dr. Summers holds an M.B.A. degree from Pepperdine University as well as a Ph.D. in International Economics from Kennedy-Western University. He is also a member of the New York Academy of Sciences, the American Association of Advancement of Science, the Houston Inventors Association, the European Vascular Society and the Society of Plastic Engineers.

M. Dwight Cantrell
M. Dwight Cantrell serves as our Chief Financial Officer, Treasurer and Director. Mr. Cantrell has maintained, and continues to maintain, a public accounting practice in the state of Texas since 1976. Mr. Cantrell is a public accountant. He has an extensive background in the banking and venture capital markets and is a member of the Association of Biotech Financial Officers. He has served as CFO since 1997.

Dr. Diane Dottavio
Dr. Diane Dottavio serves as our Director of Research and Development. Prior to joining us in March 2000, Dr. Dottavio served as Senior Scientist with Leukosite, Inc., from 1994 to 1996, and as Director of Laboratory Instruction and Research at the University of Houston, from 1996 to 2000. Ms. Dottavio holds a B.S. in Biology and a M.S. in Organic Chemistry from the University of New Mexico, as well as a Ph.D. in Biochemistry from the University of Texas.